PT1404327E - Composicao dermatologica que compreende acido nicotinico ou uma amida e uma base esfingoide - Google Patents

Composicao dermatologica que compreende acido nicotinico ou uma amida e uma base esfingoide

Info

Publication number
PT1404327E
PT1404327E PT02732833T PT02732833T PT1404327E PT 1404327 E PT1404327 E PT 1404327E PT 02732833 T PT02732833 T PT 02732833T PT 02732833 T PT02732833 T PT 02732833T PT 1404327 E PT1404327 E PT 1404327E
Authority
PT
Portugal
Prior art keywords
dermatological composition
nicothinic
comprehenses
sphinx
frost
Prior art date
Application number
PT02732833T
Other languages
English (en)
Inventor
Allart Jean-Claude
Lefevre Jean-Marie
Peyrot Jacques
Original Assignee
Dermaconcept Jmc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8862592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1404327(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dermaconcept Jmc filed Critical Dermaconcept Jmc
Publication of PT1404327E publication Critical patent/PT1404327E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT02732833T 2001-04-23 2002-04-17 Composicao dermatologica que compreende acido nicotinico ou uma amida e uma base esfingoide PT1404327E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0105451A FR2823671B1 (fr) 2001-04-23 2001-04-23 Composition dermatologique comprenant l'acide nicotinique ou un amide, et une base sphingoide

Publications (1)

Publication Number Publication Date
PT1404327E true PT1404327E (pt) 2006-10-31

Family

ID=8862592

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02732833T PT1404327E (pt) 2001-04-23 2002-04-17 Composicao dermatologica que compreende acido nicotinico ou uma amida e uma base esfingoide

Country Status (17)

Country Link
US (1) US20040170591A1 (pt)
EP (1) EP1404327B1 (pt)
AT (1) ATE331516T1 (pt)
AU (1) AU2002304546A1 (pt)
BR (1) BR0205096A (pt)
CA (1) CA2443939A1 (pt)
CY (1) CY1106442T1 (pt)
DE (1) DE60212842T2 (pt)
DZ (1) DZ3504A1 (pt)
ES (1) ES2263781T3 (pt)
FR (1) FR2823671B1 (pt)
IL (1) IL158455A0 (pt)
MA (1) MA27014A1 (pt)
PT (1) PT1404327E (pt)
RU (1) RU2297224C2 (pt)
TN (1) TNSN03102A1 (pt)
WO (1) WO2002085362A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1684675A (zh) * 2002-08-14 2005-10-19 金泰润 用于诱导细胞凋亡的含有植物鞘氨醇衍生物的组合物
FR2868702B1 (fr) * 2004-04-09 2006-12-22 Negma Lerads Soc Par Actions S Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant
FR2943914A1 (fr) * 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique Flacon mousseur comprenant une composition pharmaceutique
DE102011109546A1 (de) * 2011-08-03 2013-02-07 Evonik Goldschmidt Gmbh Verwendung von Sphinganin zur Verbesserung des visuellen Erscheinungsbildes von Haut und Haar
EP3061501A1 (en) * 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
WO2021204223A1 (zh) * 2020-04-08 2021-10-14 扬子江药业集团南京海陵药业有限公司 一种包含烟酰胺的药物组合物
CA3231023A1 (en) * 2021-09-15 2023-03-23 Nat Adkins Ointments for treating dry skin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
GB9308103D0 (en) * 1993-04-20 1993-06-02 Unilever Plc Cosmetic composition
JP3508042B2 (ja) * 1995-04-17 2004-03-22 カネボウ株式会社 セラミド合成促進剤
US5882665A (en) * 1997-11-18 1999-03-16 Elizabeth Arden Co., Division Of Conopco, Inc. Phytosphingosine salicylates in cosmetic compositions
DE19810999A1 (de) * 1998-03-13 1999-09-16 Dermapharm Gmbh Verwendung von Sphingosin, Sphingosin-1-Phosphat, Sphingosin-1-Phosphat-Derivaten und/oder deren Gemischen zur Behandlung von entzündlichen Hautkrankheiten
EP1063964A1 (en) * 1998-03-16 2001-01-03 The Procter & Gamble Company Moisturizing compositions
JP3884581B2 (ja) * 1998-10-05 2007-02-21 花王株式会社 ニキビ予防・改善剤
FR2868702B1 (fr) * 2004-04-09 2006-12-22 Negma Lerads Soc Par Actions S Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant

Also Published As

Publication number Publication date
WO2002085362A3 (fr) 2004-01-22
MA27014A1 (fr) 2004-12-20
FR2823671B1 (fr) 2004-01-09
TNSN03102A1 (fr) 2005-12-23
ES2263781T3 (es) 2006-12-16
US20040170591A1 (en) 2004-09-02
EP1404327B1 (fr) 2006-06-28
IL158455A0 (en) 2004-05-12
DZ3504A1 (fr) 2002-10-31
BR0205096A (pt) 2003-03-25
RU2003133986A (ru) 2005-03-10
AU2002304546A1 (en) 2002-11-05
FR2823671A1 (fr) 2002-10-25
DE60212842D1 (de) 2006-08-10
CA2443939A1 (fr) 2002-10-31
ATE331516T1 (de) 2006-07-15
DE60212842T2 (de) 2007-06-28
WO2002085362A2 (fr) 2002-10-31
EP1404327A2 (fr) 2004-04-07
CY1106442T1 (el) 2011-10-12
RU2297224C2 (ru) 2007-04-20

Similar Documents

Publication Publication Date Title
PL1841743T3 (pl) Amidy kwasu 3-arylo-3-hydroksy-2-aminopropionowego, amidy kwasu 3-heteroarylo-3-hydroksy-2-aminopropionowego i powiązane związki o działaniu przeciwbólowym i/lub immunostymulacyjnym
NO973821L (no) Inhibitorer for mikrosomalt triglyserid-overföringsprotein og fremgangsmåte
RS16704A (en) Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
BRPI0508525A (pt) concentrados de suspensão em base de óleo
DE60221421D1 (de) Standardisierte extrakte von scutellaria lateriflora
BR0313792A (pt) Utilização de proteìna de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
PT1404327E (pt) Composicao dermatologica que compreende acido nicotinico ou uma amida e uma base esfingoide
MX2010001657A (es) Reguladores de mmp-9 y usos de los mismos.
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
BR0215027A (pt) Derivados de 6-aminomorfinano, processo de preparação para o mesmo e sua aplicação
AU2003238347A8 (en) Method for the microbial production of aromatic amino acids and other metabolites of the aromatic amino acid biosynthetic pathway
WO2005066116A8 (en) Disubstituted chalcone oximes as selective agonists of rarϝ retinoid receptors
BR9906998A (pt) Método e composições para reduzir o envelhecimento dermatológico e para reduzir contusões
WO2006023654A3 (en) Awat-related methods and articles
FR2804286B1 (fr) Utilisation de derives de polyaminoacides comme agents conservateurs, compositions les comprenant et procede de conservation les utilisant
ATE491537T1 (de) Einschubverfahren von maschineneinheiten in eine produktionslinie
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
Rascle Testing the mediating role of appraised stress and coping strategies on employee adjustment in a context of job mobility.
NO20033705L (no) Fremgangsmåte for fremstilling av D-pantotensyre og/eller salter som tilsetning til dyrefôr
RS50900B (sr) Postupak za pripremanje nevirapina
NO20033707L (no) Fremgangsmåte for fremstilling av D-pantotensyre og/eller salter som tilsetning til dyrefôr
NO20033706L (no) Fremgangsmåte for fremstilling av D-pantotensyre og/eller salter som tilsetning til dyrefôr
ATE398621T1 (de) 1,2-diaza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung
IT1318019B1 (it) Apparecchiatura per la realizzazione di fresature in travi di legno,per l'inserimento di putrelle e simili.
WO2003031983A3 (de) Verfahren zum nachweis von aminosäuren